These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2641695)

  • 1. Port-A-Cath in children during long-term chemotherapy: complications and outcome.
    al-Hathal M; Malmfors G; Garwicz S; Békássy AN
    Pediatr Hematol Oncol; 1989; 6(1):17-22. PubMed ID: 2641695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central venous catheter with subcutaneous injection port (Port-A-Cath): clinical experience with children.
    Wesenberg F; Anker C; Sommerschild H; Flaatten H
    Pediatr Hematol Oncol; 1987; 4(2):137-43. PubMed ID: 3155237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central venous catheters for chemotherapy of solid tumors--our results in the last 5 years.
    Zganjer M; Cizmić A; Butković D; Matolić M; Karaman-Ilić M; Stepan J
    Coll Antropol; 2008 Sep; 32(3):767-70. PubMed ID: 18982750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central venous catheter-associated bloodstream infections.
    Newman N; Issa A; Greenberg D; Kapelushnik J; Cohen Z; Leibovitz E
    Pediatr Blood Cancer; 2012 Aug; 59(2):410-4. PubMed ID: 22535579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman.
    D'Souza PC; Kumar S; Kakaria A; Al-Sukaiti R; Al-Baimani K; Hamid RS; Mittal AK; Al-Balushi M; Burney IA; Al-Moundhri MS
    Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e103-e109. PubMed ID: 33777430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.
    Ng F; Mastoroudes H; Paul E; Davies N; Tibballs J; Hochhauser D; Mayer A; Begent R; Meyer T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):551-6. PubMed ID: 17517500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Port-A-Cath insertions in acute leukemia: does thrombocytopenia affect morbidity?
    Loh AH; Chui CH
    J Pediatr Surg; 2007 Jul; 42(7):1180-4. PubMed ID: 17618877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children.
    Matsuzaki A; Suminoe A; Koga Y; Hatano M; Hattori S; Hara T
    Support Care Cancer; 2006 Feb; 14(2):153-60. PubMed ID: 15999262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central venous catheter with subcutaneous injection port (Port-A-Cath): 8 years clinical follow up with children.
    Wesenberg F; Flaatten H; Janssen CW
    Pediatr Hematol Oncol; 1993; 10(3):233-9. PubMed ID: 8217538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Port-A-Cath insertions in acute leukaemia and childhood malignancies.
    Loh AH; Chui CH
    Asian J Surg; 2007 Jul; 30(3):193-9. PubMed ID: 17638639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
    Subramaniam A; Kim KH; Bryant SA; Kimball KJ; Huh WK; Straughn JM; Estes JM; Alvarez RD
    Gynecol Oncol; 2011 Oct; 123(1):54-7. PubMed ID: 21742372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences with the use of the Port-a-Cath in children.
    Soucy P
    J Pediatr Surg; 1987 Aug; 22(8):767-9. PubMed ID: 3656030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Neutropenia at the Time of Implantable Subcutaneous Chest Port Insertion Is Not a Risk Factor for Port Removal at a Tertiary Pediatric Center.
    Hoss DR; Bedros AA; Mesipam A; Criddle J; Smith JC
    J Vasc Interv Radiol; 2017 Mar; 28(3):398-402. PubMed ID: 28034702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Port-A-Cath infections in children with cancer.
    Hengartner H; Berger C; Nadal D; Niggli FK; Grotzer MA
    Eur J Cancer; 2004 Nov; 40(16):2452-8. PubMed ID: 15519519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Permanent central venous catheters in oncologic patients].
    Schrøder M; Pedersen IR; Rasmussen RB
    Ugeskr Laeger; 1991 Sep; 153(36):2491-4. PubMed ID: 1926604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation.
    Garajová I; Nepoti G; Paragona M; Brandi G; Biasco G
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):125-32. PubMed ID: 22966988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of central venous catheterization and complications in a tertiary pediatric intensive care unit.
    Tolunay İ; Yıldızdaş RD; Elçi H; Alabaz D
    Turk J Pediatr; 2018; 60(1):63-69. PubMed ID: 30102481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripherally inserted central catheters in the treatment of children with cancer: Results of a multicenter study.
    Rykov MY; Zaborovskij SV; Shvecov AN; Shukin VV
    J Vasc Access; 2018 Jul; 19(4):378-381. PubMed ID: 29546772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of central venous catheters in paediatric oncology treatment.
    Selldén H; Lannering B; Marky I; Nilsson K
    Acta Anaesthesiol Scand; 1991 May; 35(4):315-9. PubMed ID: 1853692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.